This study is in progress, not accepting new patients
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Mandar Aras
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Mandar Aras
My clinical interests are in the evaluation and management of patients with advanced heart failure and pulmonary hypertension, including patients requiring heart transplantation and left ventricular assist devices. I have a particular interest in prevention and treatment of patients with heart disease related to chemotherapy.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Pfizer
- ID
- NCT02791230
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Last Updated